跳至主要内容
临床试验/JPRN-UMIN000006417
JPRN-UMIN000006417已完成未知

Investigation of biological and clinical predictor of antidepressant response for personalized medicine in depression ; a randomized controlled trial - Genotype Utility Needed for Depression Antidepressant Medication (GUNDAM)

Kansai Medical University Department of Neuropsychiatry0 个研究点目标入组 154 人开始时间: 2011年9月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
154

研究概览

简要总结

Mirtazapine showed significantly faster improvement compared to SSRIs. Somnolence rate was higher in mirtazapine and nausea rate was higher in SSRIs. Combination therapy showed a more favorable time course than SSRIs monotherapy.

研究设计

研究类型
Interventional

入排标准

年龄范围
18years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Subjects with clinically significant unstable medical illness, pregnancy, a principal psychiatric diagnosis other than major depression, a history of substance abuse or dependence active within the previous 6 months, and electroconvulsive therapy within the previous 6 months were excluded.

研究者

发起方
Kansai Medical University Department of Neuropsychiatry

相似试验